This is often used for studies focusing on maintaining gut lining integrity or as a baseline for general wellness research
Join the early-access list for launch-day pricing, first-batch allocations, and a heads-up when doors open
Your clinician will determine the route, dose, and titration schedule based on your goals, prior GLP1 exposure, sideeffect tolerance, and medical history
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
No therapeutic claims are made or implied
Abstract Plant glutathione S-transferases (GSTs) are ubiquitous and multifunctional enzymes encoded by large gene families